154 related articles for article (PubMed ID: 7874378)
1. In vivo binding characteristics of carbamazepine and carbamazepine 10, 11-epoxide to serum proteins in monotherapy adult patients.
Kodama Y; Kuranari M; Tsutsumi K; Okamoto T; Kodama H; Yasunaga F; Fujii I; Takeyama M
Int J Clin Pharmacol Ther; 1994 Nov; 32(11):618-21. PubMed ID: 7874378
[TBL] [Abstract][Full Text] [Related]
2. In vivo binding characteristics of carbamazepine and carbamazepine-10,11-epoxide to serum proteins in paediatric patients with epilepsy.
Kodama Y; Tsutsumi K; Kuranari M; Kodama H; Fujii I; Takeyama M
Eur J Clin Pharmacol; 1993; 44(3):291-3. PubMed ID: 8491247
[TBL] [Abstract][Full Text] [Related]
3. Determinants of carbamazepine and carbamazepine 10,11-epoxide binding to serum protein, albumin and alpha 1-acid glycoprotein.
MacKichan JJ; Zola EM
Br J Clin Pharmacol; 1984 Oct; 18(4):487-93. PubMed ID: 6487490
[TBL] [Abstract][Full Text] [Related]
4. Alpha 1-acid glycoprotein concentration and serum protein binding of carbamazepine and carbamazepine-10,11 epoxide in children with epilepsy.
Contin M; Riva R; Albani F; Perucca E; Lamontanara G; Baruzzi A
Eur J Clin Pharmacol; 1985; 29(2):211-4. PubMed ID: 4076320
[TBL] [Abstract][Full Text] [Related]
5. In vivo determinations of carbamazepine and carbamazepine-10, 11-epoxide binding parameters to serum proteins in monotherapy patients.
Kodama Y; Kuranari M; Kodama H; Fujii I; Takeyama M
J Clin Pharmacol; 1993 Sep; 33(9):851-5. PubMed ID: 8227483
[TBL] [Abstract][Full Text] [Related]
6. Total and free serum concentrations of carbamazepine and carbamazepine-10,11-epoxide in children with epilepsy.
Agbato OA; Elyas AA; Patsalos PN; Brett EM; Lascelles PT
Arch Neurol; 1986 Nov; 43(11):1111-6. PubMed ID: 3778243
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of carbamazepine and carbamazepine-epoxide protein binding in patients undergoing epilepsy surgery.
Gidal BE; Spencer NW; Maly MM; Pitterle ME
Epilepsia; 1996 Apr; 37(4):381-5. PubMed ID: 8603645
[TBL] [Abstract][Full Text] [Related]
8. The epoxide of carbamazepine.
McKauge L; Tyrer JH; Eadie MJ
Clin Exp Neurol; 1979; 16():95-104. PubMed ID: 550961
[TBL] [Abstract][Full Text] [Related]
9. Carbamazepine and its epoxide: an open study of efficacy and side effects after carbamazepine dose increment in refractory partial epilepsy.
Semah F; Gimenez F; Longer E; Laplane D; Thuillier A; Baulac M
Ther Drug Monit; 1994 Dec; 16(6):537-40. PubMed ID: 7878690
[TBL] [Abstract][Full Text] [Related]
10. Altered serum protein binding of carbamazepine in disease states associated with an increased alpha 1-acid glycoprotein concentration.
Baruzzi A; Contin M; Perucca E; Albani F; Riva R
Eur J Clin Pharmacol; 1986; 31(1):85-9. PubMed ID: 3780833
[TBL] [Abstract][Full Text] [Related]
11. Comparison of equations for predicting bound serum concentrations of carbamazepine and carbamazepine-10, 11-epoxide after polytherapy in patients with epilepsy.
Kodama Y; Kuranari M; Kodama H; Tsutsumi K; Fujii I; Takeyama M
J Clin Pharmacol; 1995 Oct; 35(10):995-1002. PubMed ID: 8568018
[TBL] [Abstract][Full Text] [Related]
12. Factors affecting serum protein binding of cocaine in humans.
Parker RB; Williams CL; Laizure SC; Lima JJ
J Pharmacol Exp Ther; 1995 Nov; 275(2):605-10. PubMed ID: 7473145
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of serum protein binding of felodipine.
Valle M; Esteban M; Rodríguez-Sasiaín JM; Calvo R; Aguirre C
Res Commun Mol Pathol Pharmacol; 1996 Oct; 94(1):73-88. PubMed ID: 8948016
[TBL] [Abstract][Full Text] [Related]
14. The significance of the simultaneous determination of carbamazepine and its 10,11-epoxide from plasma and human erythrocytes.
Pynnönen S; Yrjänä T
Int J Clin Pharmacol Biopharm; 1977 May; 15(5):222-6. PubMed ID: 873665
[TBL] [Abstract][Full Text] [Related]
15. Age- and gender-related differences in carbohydrate concentrations of alpha1-acid glycoprotein variants and the effects of glycoforms on their drug-binding capacities.
Kishino S; Nomura A; Itoh S; Nakagawa T; Takekuma Y; Sugawara M; Furukawa H; Todo S; Miyazaki K
Eur J Clin Pharmacol; 2002 Dec; 58(9):621-8. PubMed ID: 12483455
[TBL] [Abstract][Full Text] [Related]
16. Binding of bupivacaine to human serum proteins, isolated albumin and isolated alpha-1-acid glycoprotein. Differences between the two enantiomers are partly due to cooperativity.
Mazoit JX; Cao LS; Samii K
J Pharmacol Exp Ther; 1996 Jan; 276(1):109-15. PubMed ID: 8558418
[TBL] [Abstract][Full Text] [Related]
17. Interaction between human serum albumin and alpha 1-acid glycoprotein in the binding of lidocaine to purified protein fractions and sera.
Krauss E; Polnaszek CF; Scheeler DA; Halsall HB; Eckfeldt JH; Holtzman JL
J Pharmacol Exp Ther; 1986 Dec; 239(3):754-9. PubMed ID: 3795040
[TBL] [Abstract][Full Text] [Related]
18. Carbamazepine-10,11-epoxide in epilepsy. A pilot study.
Tomson T; Almkvist O; Nilsson BY; Svensson JO; Bertilsson L
Arch Neurol; 1990 Aug; 47(8):888-92. PubMed ID: 2375696
[TBL] [Abstract][Full Text] [Related]
19. Interactions of serum albumin, valproic acid and carbamazepine with the pharmacokinetics of phenytoin in cancer patients.
Joerger M; Huitema AD; Boogerd W; van der Sande JJ; Schellens JH; Beijnen JH
Basic Clin Pharmacol Toxicol; 2006 Aug; 99(2):133-40. PubMed ID: 16918714
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of cardiac conduction disturbances during carbamazepine treatment: preliminary data.
Spina E; Kenneback G; Bergfeldt L; Tomson T
Funct Neurol; 1987; 2(4):563-7. PubMed ID: 3443382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
